Enovix Corporation (NASDAQ:ENVX – Get Free Report) has been given an average rating of “Hold” by the ten research firms that are presently covering the company, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell recommendation, two have given a hold recommendation and six have assigned a buy recommendation to the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $12.50.
ENVX has been the topic of a number of analyst reports. TD Cowen reduced their price target on Enovix from $7.00 to $5.50 and set a “hold” rating on the stock in a research report on Friday, July 24th. Craig Hallum lowered their price objective on Enovix from $10.00 to $8.00 and set a “buy” rating for the company in a research report on Thursday, May 14th. Wall Street Zen upgraded shares of Enovix from a “strong sell” rating to a “sell” rating in a research note on Saturday, May 16th. JPMorgan Chase & Co. cut shares of Enovix from a “neutral” rating to an “underweight” rating in a report on Wednesday, May 6th. Finally, Oppenheimer decreased their price target on shares of Enovix from $24.00 to $21.00 and set an “outperform” rating for the company in a research note on Thursday, May 14th.
Get Our Latest Report on Enovix
Enovix Stock Up 3.2%
Enovix (NASDAQ:ENVX – Get Free Report) last released its earnings results on Wednesday, May 13th. The company reported ($0.14) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.15) by $0.01. Enovix had a negative return on equity of 64.28% and a negative net margin of 499.64%.The firm had revenue of $7.60 million during the quarter, compared to analyst estimates of $6.95 million. During the same period last year, the business posted ($0.15) earnings per share. Enovix’s revenue was up 49.1% compared to the same quarter last year. Enovix has set its Q2 2026 guidance at -0.170–0.130 EPS. As a group, equities analysts expect that Enovix will post -0.79 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Enovix
Institutional investors have recently modified their holdings of the company. Vanguard Group Inc. boosted its position in shares of Enovix by 10.9% during the 4th quarter. Vanguard Group Inc. now owns 17,760,708 shares of the company’s stock worth $129,831,000 after acquiring an additional 1,747,145 shares in the last quarter. Millennium Management LLC increased its holdings in shares of Enovix by 1,038.9% in the 3rd quarter. Millennium Management LLC now owns 1,476,879 shares of the company’s stock valued at $14,724,000 after acquiring an additional 1,347,200 shares during the last quarter. Two Sigma Investments LP raised its position in shares of Enovix by 9,197.1% during the 3rd quarter. Two Sigma Investments LP now owns 1,200,997 shares of the company’s stock worth $11,974,000 after acquiring an additional 1,188,079 shares in the last quarter. Barclays PLC raised its position in shares of Enovix by 263.1% during the 4th quarter. Barclays PLC now owns 1,551,941 shares of the company’s stock worth $11,345,000 after acquiring an additional 1,124,480 shares in the last quarter. Finally, Electron Capital Partners LLC lifted its stake in Enovix by 13.8% during the third quarter. Electron Capital Partners LLC now owns 8,038,396 shares of the company’s stock worth $80,143,000 after purchasing an additional 972,103 shares during the last quarter. 50.92% of the stock is owned by hedge funds and other institutional investors.
About Enovix
Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.
Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.
Featured Stories
- Five stocks we like better than Enovix
- SpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have Control
- Why Rare Earth Processing Could Be the Real 2027 Opportunity
- The S&P 493 Are Staging a Comeback—This Value ETF Offers Broad Exposure
- TSMC Insiders Are Buying the Pullback—But Is the Signal as Bullish as It Looks?
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.
